Izaskun Villar-Menéndez

Increased 5-Methylcytosine and Decreased 5-Hydroxymethylcytosine Levels are Associated with Reduced Striatal A2AR Levels in Huntington’s Disease

Izaskun Villar-Menéndez, Marta Blanch, Shiraz Tyebji et al. · NeuroMolecular Medicine · 2013 · 142 citations

Neurodegenerative Diseases, Neurobiology Of Disease, Huntington ’ +9

Increased striatal adenosine A2A receptor levels is an early event in Parkinson’s disease-related pathology and it is potentially regulated by miR-34b

Izaskun Villar-Menéndez, Sílvia Porta, Sandra P. Buira et al. · Neurobiology of Disease · 2014 · 106 citations · Full text

Neurodegenerative Diseases, Parkinson ’, Pathology +11

Reduced striatal adenosine A2A receptor levels define a molecular subgroup in schizophrenia

Izaskun Villar-Menéndez, Sara Díaz-Sánchez, Marta Blanch et al. · Journal of Psychiatric Research · 2014 · 45 citations

Psychiatry, Molecular Subgroup, Psychotic Disorder +9

Reduced striatal ecto-nucleotidase activity in schizophrenia patients supports the “adenosine hypothesis”

Elisabet Aliagas, Izaskun Villar-Menéndez, Jean Sévigny et al. · Purinergic Signalling · 2013 · 29 citations · Full text

Psychiatry, Neurophysiology, Medicine +11

Striatal adenosine A2A receptor expression is controlled by S-adenosyl-L-methionine-mediated methylation

Izaskun Villar-Menéndez, Fabiana Núñez, Sara Díaz-Sánchez et al. · Purinergic Signalling · 2014 · 17 citations · Full text

Molecular Physiology, Signal Transduction, Biochemistry +9